News
CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.
As part of Sanner’s strategic transformation into a Contract Development and Manufacturing Organization (CDMO) for medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback